Sign in

CIK 0001368514

  • Large accelerated filer

ADMA BIOLOGICS, INC.

Sign in to watch
Ticker
ADMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562590442
Phone
+1 201-478-5552
Business address
C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
Former names
R&R ACQUISITION VI, INC
  1. 4 Open-market buy Director bought 100,000 shares at $1.00 ($100,000)
  2. 4 Open-market buy EVP, CFO bought 30,000 shares at $1.00 ($30,000)
  3. 4 Open-market buy President and CEO bought 350,000 shares at $1.00 ($350,000)
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Grant or award EVP, CFO acquired 900,000 shares (grant or award)
  7. 4 Grant or award President and CEO acquired 1,650,000 shares (grant or award)
  8. 4 Open-market sale 10% owner sold 260,603 shares at an average $1.15 ($299,236)
  9. 4 Open-market sale 10% owner sold 500,000 shares at an average $1.25 ($622,500)
  10. 4 Open-market sale 10% owner sold 780,000 shares at $1.27 ($990,600)
  11. 4 Open-market sale 10% owner sold 1,781,824 shares at an average $1.31 ($2,333,781)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Grant or award President and CEO acquired 221,447 shares (grant or award)
  18. 4 Grant or award EVP, CSO and CMO acquired 64,361 shares (grant or award)
  19. 4 Grant or award EVP, CFO acquired 63,936 shares (grant or award)
  20. 4 Open-market buy Director bought 2,200 shares at $2.29 ($5,038)

Page 8 of 19 · 362 filings